RT Journal Article
SR Electronic
T1 Axial Spondyloarthritis Disease Activity Cutoffs at Golimumab Initiation in the French GO-PRACTICE Study: Parallels With the German GO-NICE Study
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.200172
DO 10.3899/jrheum.200172
A1 Philippe Goupille
A1 Naoual Harid
A1 René-Marc Flipo
YR 2020
UL http://www.jrheum.org/content/early/2020/10/13/jrheum.200172.abstract
AB Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disorder that includes both radiographic and nonradiographic entities1. International guidelines for axSpA management recommend nonsteroidal antiinflammatory drugs as the first line of treatment2,3